ADL
SRNE

Asset Dedication LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Asset Dedication LLC’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,771
Closed – – 1064
2023
Q1 		$0 Hold
1,771
– – ﹤0.01% 1113
2022
Q4 		$2K Hold
1,771
– – ﹤0.01% 904
2022
Q3 		$3K Buy
1,771
+800
+82% +$1.81K ﹤0.01% 805
2022
Q2 		$2K Hold
971
– – ﹤0.01% 475
2022
Q1 		$2K Hold
971
– – ﹤0.01% 899
2021
Q4 		$5K Hold
971
– – ﹤0.01% 752
2021
Q3 		$7K Hold
971
– – ﹤0.01% 761
2021
Q2 		$9K Hold
971
– – ﹤0.01% 651
2021
Q1 		$8K Hold
971
– – ﹤0.01% 530
2020
Q4 		$7K Hold
971
– – ﹤0.01% 607
2020
Q3 		$11K Hold
971
– – ﹤0.01% 519
2020
Q2 		$6K Buy
+971
New +$3.72K ﹤0.01% 522

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Asset Dedication LLC's SRNE Position: Q2 2023 in Review

Asset Dedication LLC sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 1,771 shares.

Asset Dedication LLC first reported a position in SRNE in Q2 2020 and held it in 12 quarters. The position peaked at $11K in Q3 2020. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

  • Asset Dedication LLC reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Asset Dedication LLC sold 1,771 Sorrento Therapeutics, Inc. shares in Q2 2023.
  • Asset Dedication LLC first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 12 quarters.
  • Asset Dedication LLC's Sorrento Therapeutics, Inc. position peaked at $11K in Q3 2020.
  • 9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on Asset Dedication LLC's 13F filing for Q2 2023, filed 22 Aug 2023.